相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。When to Start Antiretroviral Therapy in HIV-Associated Tuberculosis
M. Estée Török et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Integration of Antiretroviral Therapy with Tuberculosis Treatment
Salim S. Abdool Karim et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Timing of Antiretroviral Therapy for HIV-1 Infection and Tuberculosis
Diane V. Havlir et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
AIDS-defining opportunistic illnesses in US patients, 1994-2007: a cohort study
Kate Buchacz et al.
AIDS (2010)
Combination Flucytosine and High-Dose Fluconazole Compared with Fluconazole Monotherapy for the Treatment of Cryptococcal Meningitis: A Randomized Trial in Malawi
Jesse C. Nussbaum et al.
CLINICAL INFECTIOUS DISEASES (2010)
Early versus Delayed Initiation of Antiretroviral Therapy for Concurrent HIV Infection and Cryptococcal Meningitis in Sub-Saharan Africa
Azure T. Makadzange et al.
CLINICAL INFECTIOUS DISEASES (2010)
Clinical Practice Guidelines for the Management of Cryptococcal Disease: 2010 Update by the Infectious Diseases Society of America
John R. Perfect et al.
CLINICAL INFECTIOUS DISEASES (2010)
Immune reconstitution inflammatory syndrome in patients starting antiretroviral therapy for HIV infection: a systematic review and meta-analysis
Monika Müller et al.
LANCET INFECTIOUS DISEASES (2010)
Progressive Multifocal Leukoencephalopathy: What's New?
Daniele Focosi et al.
NEUROSCIENTIST (2010)
Acyclovir and Transmission of HIV-1 from Persons Infected with HIV-1 and HSV-2
C. Celum et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Timing of Initiation of Antiretroviral Drugs during Tuberculosis Therapy
Salim S. Abdool Karim et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Impact of aciclovir on ulcer healing, lesional, genital and plasma HIV-1 RNA among patients with genital ulcer disease in Malawi
Sam Phiri et al.
SEXUALLY TRANSMITTED INFECTIONS (2010)
Identification and Characterization of Mefloquine Efficacy against JC Virus In Vitro
Margot Brickelmaier et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2009)
Effect of Rifampin, a Potent Inducer of Drug-Metabolizing Enzymes, on the Pharmacokinetics of Raltegravir
Larissa A. Wenning et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2009)
Mirtazapine Use in Human Immunodeficiency Virus-Infected Patients With Progressive Multifocal Leukoencephalopathy
Deanna Cettomai et al.
ARCHIVES OF NEUROLOGY (2009)
High dose prolonged treatment with nitazoxanide is not effective for cryptosporidiosis in HIV positive Zambian children: a randomised controlled trial
Beatrice Amadi et al.
BMC INFECTIOUS DISEASES (2009)
HIV-Associated Opportunistic Infections-Going, Going, But Not Gone: The Continued Need for Prevention and Treatment Guidelines
John T. Brooks et al.
CLINICAL INFECTIOUS DISEASES (2009)
Cryptococcal Immune Reconstitution Inflammatory Syndrome after Antiretroviral Therapy in AIDS Patients with Cryptococcal Meningitis: A Prospective Multicenter Study
Somnuek Sungkanuparph et al.
CLINICAL INFECTIOUS DISEASES (2009)
Pharmacokinetic Evaluation of Rifabutin in Combination with Lopinavir-Ritonavir in Patients with HIV Infection and Active Tuberculosis
Catherine Boulanger et al.
CLINICAL INFECTIOUS DISEASES (2009)
Detection and Prediction of Active Tuberculosis Disease by a Whole-Blood Interferon-γ Release Assay in HIV-1-Infected Individuals
Maximilian C. Aichelburg et al.
CLINICAL INFECTIOUS DISEASES (2009)
Defining Immune Reconstitution Inflammatory Syndrome: Evaluation of Expert Opinion versus 2 Case Definitions in a South African Cohort
Lewis J. Haddow et al.
CLINICAL INFECTIOUS DISEASES (2009)
Immune Reconstitution Inflammatory Syndrome: A Reappraisal
Martyn A. French
CLINICAL INFECTIOUS DISEASES (2009)
Treatment options for AIDS patients with progressive multifocal leukoencephalopathy
Beatriz Hernandez et al.
EXPERT OPINION ON PHARMACOTHERAPY (2009)
Clinical efficacy of first- and second-line treatments for HIV-associated Pneumocystis jirovecii pneumonia: a tri-centre cohort study
Jannik Helweg-Larsen et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2009)
PML-IRIS in patients with HIV infection Clinical manifestations and treatment with steroids
K. Tan et al.
NEUROLOGY (2009)
Determinants of survival in progressive multifocal leukoencephalopathy
A. Marzocchetti et al.
NEUROLOGY (2009)
Inhibitory effect of serotonin antagonists on JC virus propagation in a carrier culture of human neuroblastoma cells
Souichi Nukuzuma et al.
MICROBIOLOGY AND IMMUNOLOGY (2009)
Early Antiretroviral Therapy Reduces AIDS Progression/Death in Individuals with Acute Opportunistic Infections: A Multicenter Randomized Strategy Trial
Andrew R. Zolopa et al.
PLOS ONE (2009)
Good outcome with trimethoprim 10 mg/kg/day-sulfamethoxazole 50 mg/kg/day for Pneumocystis jirovecii pneumonia in HIV infected patients
Mark Thomas et al.
SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES (2009)
Antiviral treatment for preventing postherpetic neuralgia
Qifu Li et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2009)
Patients presenting with AIDS in the HAART era: a collaborative cohort analysis
Cristina Mussini et al.
AIDS (2008)
Restoration of Toxoplasma gondii-specific immune responses in patients with AIDS starting HAART
Andre Furco et al.
AIDS (2008)
Incidence and risk factors for the immune reconstitution inflammatory syndrome in HIV patients in South Africa: a prospective study
David M. Murdoch et al.
AIDS (2008)
Single-Dose Fluconazole versus Standard 2-Week Therapy for Oropharyngeal Candidiasis in HIV-Infected Patients: A Randomized, Double-Blind, Double-Dummy Trial
Omar J. M. Hamza et al.
CLINICAL INFECTIOUS DISEASES (2008)
Resolution of severe cryptosporidial diarrhea with rifaximin in patients with AIDS
Joseph C. Gathe et al.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2008)
Second-line salvage treatment of AIDS-associated Pneumocystis jirovecii pneumonia -: A case series and systematic review
Thomas Benfield et al.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2008)
A phase 2, open-label study of the safety and efficacy of intravenous anidulafungin as a treatment for azole-refractory mucosal candidiasis
Jose A. Vazquez et al.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2008)
5-HT2a inhibitors for progressive multifocal leukoencephalopathy:: Old drugs for an old disease
Daniele Focosi et al.
JOURNAL OF INFECTIOUS DISEASES (2008)
Serotonin receptor 2A blocker (risperidone) has no effect on human polyomavirus JC infection of primary human fetal glial cells
Moti L. Chapagain et al.
JOURNAL OF NEUROVIROLOGY (2008)
Effect of aciclovir on HIV-1 acquisition in herpes simplex virus 2 seropositive women and men who have sex with men: a randomised, double-blind, placebo-controlled trial
Connie Celum et al.
LANCET (2008)
Tuberculosis-associated immune reconstitution inflammatory syndrome: case definitions for use in resource-limited settings
Graeme Meintjes et al.
LANCET INFECTIOUS DISEASES (2008)
Effect of herpes simplex suppression on incidence of HIV among women in Tanzania
Deborah Watson-Jones et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
A randomized clinical trial of chlorhexidine in the maintenance of oral candidiasis-free period in HIV infection
W. Nittayananta et al.
ORAL DISEASES (2008)
2-day versus 5-day famciclovir as treatment of recurrences of genital herpes: results of the FaST study
Neil Bodsworth et al.
SEXUAL HEALTH (2008)
Multidrug- and Extensively Drug-Resistant Tuberculosis, Germany
Barbara Eker et al.
EMERGING INFECTIOUS DISEASES (2008)
Mycobacterium avium complex immune reconstitution inflammatory syndrome:: Long term outcomes
James Riddell et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2007)
Mirtazapine in progressive multifocal leukoencephalopathy associated with polycythemia vera
Susama Verma et al.
JOURNAL OF INFECTIOUS DISEASES (2007)
Pneumocystis jiroveci pneumonia prophylaxis is not required with a CD4+ T-cell count <200 cells/μl when viral replication is suppressed
Gianni E. D'Egidio et al.
AIDS (2007)
Risperidone-induced reduction in JC viruria as a surrogate marker for efficacy against progressive multifocal leukoencephalopathy and hemorrhagic cystitis
Daniele Focosi et al.
JOURNAL OF CLINICAL VIROLOGY (2007)
Safety and efficacy of posaconazole in the long-term treatment of azole-refractory oropharyngeal and esophageal candidiasis in patients with HIV infection
J. A. Vazquez et al.
HIV CLINICAL TRIALS (2007)
Posaconazole for the treatment of azole-refractory oropharyngeal and esophageal candidiasis in subjects with HIV infection
Daniel J. Skiest et al.
CLINICAL INFECTIOUS DISEASES (2007)
An official ATS/IDSA statement: Diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases
David E. Griffith et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2007)
Tuberculosis-associated immune reconstitution disease: incidence, risk factors and impact in an antiretroviral treatment service in South Africa
Stephen D. Lawn et al.
AIDS (2007)
Prevention and treatment of cryptosporidiosis in immunocompromised patients
I. Abubakar et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2007)
Reducing tuberculosis incidence by tuberculin skin testing, preventive treatment, and antiretroviral therapy in an area of low tuberculosis transmission
Luigia Elzi et al.
CLINICAL INFECTIOUS DISEASES (2007)
Immune reconstitution inflammatory syndrome in the first year after HAART: influence on long-term clinical outcome
Wan Beom Park et al.
AIDS (2006)
Long-term outcome of AIDS-associated cryptococcosis in the era of combination antiretroviral therapy
Olivier Lortholary et al.
AIDS (2006)
Famciclovir for the treatment of recurrent genital herpes: a clinical and pharmacological perspective
Donald C. Vinh et al.
EXPERT OPINION ON PHARMACOTHERAPY (2006)
Adverse events and treatment interruption in tuberculosis patients with and without HIV coinfection
R. A. M. Breen et al.
THORAX (2006)
Discontinuation of primary and secondary Toxoplasma gondii prophylaxis is safe in HIV-infected patients after immunological restoration with highly active antiretroviral therapy:: Results of an open, randomized, multicenter clinical trial
JM Miro et al.
CLINICAL INFECTIOUS DISEASES (2006)
Immune reconstitution syndrome in HIV: Validating a case definition and identifying clinical predictors in persons initiating Antiretroviral therapy
J Robertson et al.
CLINICAL INFECTIOUS DISEASES (2006)
A multicenter randomized trial evaluating posaconazole versus fluconazole for the treatment of oropharyngeal candidiasis in subjects with HIV/AIDS
JA Vazquez et al.
CLINICAL INFECTIOUS DISEASES (2006)
Immune reconstitution inflammatory syndrome: more answers, more questions
SA Shelburne et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2006)
Incidence and risk factors for immune reconstitution inflammatory syndrome in an ethnically diverse HIV type 1-infected cohort
I Ratnam et al.
CLINICAL INFECTIOUS DISEASES (2006)
Herpes simplex virus 2 infection increases HIV acquisition in men and women: systematic review and meta-analysis of longitudinal studies
EE Freeman et al.
AIDS (2006)
Management of toxoplasmic encephalitis in HIV-infected adults (with an emphasis on resource-poor settings)
M. Dedicoat et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2006)
Nontuberculous mycobacterial immune reconstitution syndrome in HIV-infected patients: Spectrum of disease and long-term follow-up
P Phillips et al.
CLINICAL INFECTIOUS DISEASES (2005)
A randomized study of the use of fluconazole in continuous versus episodic therapy in patients with advanced HIV infection and a history of oropharyngeal candidiasis: AIDS clinical trials group study 323/Mycoses Study Group Study 40
M Goldman et al.
CLINICAL INFECTIOUS DISEASES (2005)
Prospective randomized trial of trimethoprim/sulfamethoxazole versus pyrimethamine and sulfadiazine in the treatment of ocular toxoplasmosis
M Soheilian et al.
OPHTHALMOLOGY (2005)
Activity of posaconazole in the treatment of central nervous system fungal infections
P Pitisuttithum et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2005)
A randomized, double blind, comparative trial of micafungin (FK463) vs. fluconazole for the treatment of oesophageal candidiasis
NTE de Wet et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2005)
Efficacy of chlorhexidine gluconate rinse for treatment and prevention of oral candidiasis in HIV-infected children: A pilot study
A Barasch et al.
ORAL SURGERY ORAL MEDICINE ORAL PATHOLOGY ORAL RADIOLOGY AND ENDODONTOLOGY (2004)
A randomized, double-blind trial of anidulafungin versus fluconazole for the treatment of esophageal candidiasis
DS Krause et al.
CLINICAL INFECTIOUS DISEASES (2004)
Mycobacterium avium complex in patients with HIV infection in the era of highly active antiretroviral therapy
PC Karakousis et al.
LANCET INFECTIOUS DISEASES (2004)
Prevalence, associated factors, and prognostic determinants of AIDS-related toxoplasmic encephalitis in the era of advanced highly active antiretroviral therapy
A Antinori et al.
CLINICAL INFECTIOUS DISEASES (2004)
Mucosal and systemic fungal infections in patients with AIDS - Prophylaxis and treatment
M Ruhnke
DRUGS (2004)
Disseminated Mycobacterium avium-intracellulare complex (MAC) infection in the era of effective antiretroviral therapy - Is prophylaxis still indicated
CG Lange et al.
DRUGS (2004)
Maintenance therapy with cotrimoxazole for toxoplasmic encephalitis in the era of highly active antiretroviral therapy
X Duval et al.
AIDS (2004)
Recombinant interferon-γ1b as adjunctive therapy for AIDS-related acute cryptococcal meningitis
PG Pappas et al.
JOURNAL OF INFECTIOUS DISEASES (2004)
Efficacy and safety of valacyclovir for the suppression and episodic treatment of herpes simplex virus in patients with HIV
T Warren et al.
CLINICAL INFECTIOUS DISEASES (2004)
Resistance of herpes simplex virus infections to nucleoside analogues in HIV-infected patients
MJ Levin et al.
CLINICAL INFECTIOUS DISEASES (2004)
Outcome of HIV-associated tuberculosis in the era of highly active antiretroviral therapy
K Dheda et al.
JOURNAL OF INFECTIOUS DISEASES (2004)
Combination antifungal therapies for HIV-associated cryptococcal meningitis: a randomised trial
AE Brouwer et al.
LANCET (2004)
Lack of enzyme-inducing effect of rifampicin on the pharmacokinetics of enfuvirtide
MA Boyd et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2003)
A prospective, randomized trial examining the efficacy and safety of clarithromycin in combination with ethambutol, rifabutin, or both for the treatment of disseminated Mycobacterium avium complex disease in persons with acquired immunodeficiency syndrome
CA Benson et al.
CLINICAL INFECTIOUS DISEASES (2003)
Guideline vulvovaginal candidosis: Guideline of the German Dermatological Society, the German Speaking Mycological Society and the Working Group for Infections and Infectimmunology of the German Society for Gynecology and Obstetrics
W Mendling et al.
MYCOSES (2003)
Valacyclovir for the suppression of recurrent genital herpes in human immunodeficiency virus-infected subjects
E DeJesus et al.
JOURNAL OF INFECTIOUS DISEASES (2003)
Voriconazole treatment for less-common, emerging, or refractory fungal infections
JR Perfect et al.
CLINICAL INFECTIOUS DISEASES (2003)
Clinical course and prognostic factors of progressive multifocal leukoencephalopathy in patients treated with highly active antiretroviral therapy
J Berenguer et al.
CLINICAL INFECTIOUS DISEASES (2003)
Discontinuation of secondary prophylaxis for Pneumocystis carinii pneumonia in human immunodeficiency virus-infected patients:: A randomized trial by the CIOP Study group
C Mussini et al.
CLINICAL INFECTIOUS DISEASES (2003)
A randomized double-blind study of caspofungin versus fluconazole for the treatment of esophageal candidiasis
A Villanueva et al.
AMERICAN JOURNAL OF MEDICINE (2002)
Noninvasive ventilation for treating acute respiratory failure in AIDS patients with pneumocystis carinii pneumonia
M Confalonieri et al.
INTENSIVE CARE MEDICINE (2002)
Herpes zoster
JW Gnann et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Pneumocystis carinii pneumonia after the discontinuation of secondary prophylaxis
O Degen et al.
AIDS (2002)
A prospective, randomized trial of pyrimethamine and azithromycin vs pyrimethamine and sulfadiazine for the treatment of ocular toxoplasmosis
LH Bosch-Driessen et al.
AMERICAN JOURNAL OF OPHTHALMOLOGY (2002)
Randomized phase II trial of atovaquone with pyrimethamine or sulfadiazine for treatment of toxoplasmic encephalitis in patients with acquired immunodeficiency syndrome: ACTG 237/ANRS 039 study
K Chirgwin et al.
CLINICAL INFECTIOUS DISEASES (2002)
A controlled trial of valganciclovir as induction therapy for cytomegalovirus retinitis.
DF Martin et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Resistance of Candida species to antifungal agents:: molecular mechanisms and clinical consequences
D Sanglard et al.
LANCET INFECTIOUS DISEASES (2002)
Efficacy of trimethoprim-sulfamethoxazole for the prevention of bacterial, infections in a randomized prophylaxis trial of patients with advanced HIV infection
AG Dirienzo et al.
AIDS RESEARCH AND HUMAN RETROVIRUSES (2002)
Treatment of tuberculosis in HIV-infected persons in the era of highly active antiretroviral therapy
GL Dean et al.
AIDS (2002)
Valaciclovir versus aciclovir for herpes simplex virus infection in HIV-infected individuals: two randomized trials
MA Conant et al.
INTERNATIONAL JOURNAL OF STD & AIDS (2002)
Clinical and virologic characterization of acyclovir-resistant varicella-zoster viruses isolated from 11 patients with acquired immunodeficiency syndrome
E Saint-Léger et al.
CLINICAL INFECTIOUS DISEASES (2001)
HIV-1 and recurrence, relapse, and reinfection of tuberculosis after cure: a cohort study in South African mineworkers
P Sonnenberg et al.
LANCET (2001)
Incidence and risk factors for toxoplasmic encephalitis in human immunodeficiency virus-infected patients before and during the highly active antiretroviral therapy era
S Abgrall et al.
CLINICAL INFECTIOUS DISEASES (2001)
A randomized double-blind study of caspofungin versus amphotericin for the treatment of candidal esophagitis
A Villanueva et al.
CLINICAL INFECTIOUS DISEASES (2001)
A randomized, double-blind, double-dummy, multicenter trial of voriconazole and fluconazole in the treatment of esophageal candidiasis in immunocompromised patients
R Ally et al.
CLINICAL INFECTIOUS DISEASES (2001)
Trimethoprim-sulfamethoxazole (TMP-SMZ) dose escalation versus direct rechallenge for Pneumocystis carinii pneumonia prophylaxis in human immunodeficiency virus-infected patients with previous adverse reaction to TMP-SMZ
GS Leoung et al.
JOURNAL OF INFECTIOUS DISEASES (2001)
Treatment of HIV-related tuberculosis in the era of effective antiretroviral therapy
WJ Burman et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2001)
Treatment of diarrhea caused by Cryptosporidium parvum:: A prospective randomized, double-blind, placebo-controlled study of nitazoxanide
JFA Rossignol et al.
JOURNAL OF INFECTIOUS DISEASES (2001)
Immune recovery under highly active antiretroviral therapy is associated with restoration of lymphocyte proliferation and interferon-γ production in the presence of Toxoplasma gondii antigens
S Fournier et al.
JOURNAL OF INFECTIOUS DISEASES (2001)
Paromomycin in cryptosporidiosis
AC White et al.
CLINICAL INFECTIOUS DISEASES (2001)
Pneumocystis carinii pneumonia recurrence in HIV patients on highly active antiretroviral therapy:: Secondary prophylaxis
S Abgrall et al.
JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2001)
Atovaquone suspension for treatment of Pneumocystis carinii pneumonia in HIV-infected patients
DM Rosenberg et al.
AIDS (2001)
A randomized trial of the discontinuation of primary and secondary prophylaxis against Pneumocystis carinii pneumonia after highly active antiretroviral therapy in patients with HIV infection.
JCLB de Quiros et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
Discontinuation of maintenance therapy for cytomegalovirus retinitis in HIV-infected patients receiving highly active antiretroviral therapy
M Jouan et al.
AIDS (2001)
Effect of potent antiretroviral therapy on immune responses to Mycobacterium avium in human immunodeficiency virus-infected subjects
DV Havlir et al.
JOURNAL OF INFECTIOUS DISEASES (2000)
A randomized, double-blind trial comparing azithromycin and clarithromycin in the treatment of disseminated Mycobacterium avium infection in patients with human immunodeficiency virus
M Dunne et al.
CLINICAL INFECTIOUS DISEASES (2000)
Eradication of cryptosporidia and microsporidia following successful antiretroviral therapy
YM Miao et al.
JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2000)
Paromomycin: No more effective than placebo for treatment of cryptosporidiosis in patients with advanced human immunodeficiency virus infection
RG Hewitt et al.
CLINICAL INFECTIOUS DISEASES (2000)
A comparison of topical application of penciclovir 1% cream with acyclovir 3% cream for treatment of genital herpes: a randomized, double-blind, multicentre trial
XS Chen et al.
INTERNATIONAL JOURNAL OF STD & AIDS (2000)
Treatment of cytomegalovirus retinitis with an intraocular sustained-release ganciclovir implant
C Muccioli et al.
BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH (2000)
Valaciclovir - A review of its long term utility in the management of genital herpes simplex virus and cytomegalovirus infections
D Ormrod et al.
DRUGS (2000)
Thrice-weekly sulfadiazine-pyrimethamine for maintenance therapy of toxoplasmic encephalitis in HIV-infected patients
D Podzamczer et al.
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES (2000)